DUOPHARMA BIOTECH BERHAD
KLSE (MYR): DPHARMA (7148)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
1.25
Today's Change
-0.01 (0.79%)
Day's Change
1.24 - 1.25
Trading Volume
99,500
Profile
DUOPHARMA BIOTECH BERHAD
Exchange: Bursa Malaysia Bursa Malaysia
Country Code: MY MY
Currency: MYR MYR
Sector: HEALTH CARE HEALTH CARE
Subsector: PHARMACEUTICALS PHARMACEUTICALS
Index Group: HEALTH CARE HEALTH CARE
Category: ORDINARY SHARE ORDINARY SHARE
Syariah Flag: Yes Yes
Short Sell Flag: Yes Yes
IDSS Flag: Yes Yes
Description
Duopharma Biotech Berhad, an investment holding company, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia. The company provides products in various forms, including tablets, capsules, syrups, oral antibiotics, creams, hemodialysis solutions, sterile irrigation solutions, sterile powder and small volume injectable forms, dental cartridges, and eye drop preparations. It offers generic and halal pharmaceutical products; and over-the-counter products primarily under the Champs, Flavettes, Proviton, Naturalle, Uphamol, Eye Glo, Donna, and Alucid brands, as well as analgesics, antihistamines, etc. The company also operates under the OMESEC brand name. In addition, it is also involved in the property management activities; and distribution of chemical products. Duopharma Biotech Berhad also exports its products to Vietnam, Ethiopia, Sudan, Southeast Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, the Republic of Yemen, Singapore, and Hong Kong. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. The company was founded in 1979 and is based in Klang, Malaysia. Duopharma Biotech Berhad is a subsidiary of Permodalan Nasional Berhad.
Address
Discussions
13 people like this. Showing 50 of 12,449 comments
Managed and operated by white haired people sitting in wheel chairs and using walking sticks. Most have prostate problems, waking few times at night to urinate. Some are waiting for stairways to Heavens........HOW COULD COMPANY BE AGGRESSIVE???
2023-10-08 13:10
3Q23 profits down 45% YoY....current BOD is a team of silver haired centennials in wheelchairs. Raising 2 Billion bonds for retirement benefits?
BOD too aggressive is bad, weak BOD is also bad.......take your pick.
2023-11-10 12:07
Pharma is dying, yet this ctnr with Management in wheelchairs cannot take advantage.
2023-12-02 09:04
This is just reaction to Covid case spike, after that fall back down. Nothing new and exciting on the horizon for pharma in the coming months especially when Pharmaniaga still in the dump and government cutting back on spending.
2023-12-15 16:03
Hope this collaboration can bring good revenue to the company for Fy2024 and so on
https://theedgemalaysia.com/node/692365
2024-01-15 17:14
Duopharma Biotech Bhd is likely to see a recovery in its consumer healthcare (CHC) segment, while sales to the government sector is also expected to increase in 2024.
https://www.thestar.com.my/business/business-news/2024/01/26/duopharma-earnings-set-to-improve-this-year
2024-01-30 17:36
Duopharma Biotech Clinches MYR578 million Supply Deals
https://www.tradingview.com/news/mtnewswires.com:20240501:G2361746:0/
2024-05-02 09:21
Yuhoo!!! Finally Duo making big move. 1.40 seems reasonable figure to relief breath.
2024-05-02 19:09
Ayo!!! What has 600m contract do to the Duo's share price??? Sometime the illogical happen.....
2024-05-04 18:39
Keep & follow TP from OSK
https://klse.i3investor.com/web/pricetarget/research/71461
2024-05-28 14:28
That is 1-year low price for Dpharma dude
fruitcake
1.10 please
19 hours ago
2024-06-14 11:03
Haha unfortunately i'm closing my position with Dpharma, feels like watching paint dry. Anyways good luck guys.
2024-06-26 11:32
I think they have. https://www.freemalaysiatoday.com/category/nation/2016/01/28/viagra-no-longer-hard-to-get/
2024-07-04 11:46
Duopharma Biotech 2Q net profit up 33%, pays one sen dividend 🔥
https://theedgemalaysia.com/node/722957
2024-08-16 11:40
DPHARMA: Reaping the Rewards of a Strong Ringgit
https://klse.i3investor.com/web/blog/detail/bestStocks/2024-09-26-story-h470048636-DPHARMA_Reaping_the_Rewards_of_a_Strong_Ringgit
2024-09-26 12:28
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
Mercury Securities Research
2
Stock Market Enthusiast
3
THE INVESTMENT APPROACH OF CALVIN TAN
4
5
Phillip Capital Research Reports
6
save malaysia!
7
Good Articles to Share
8
Good Articles to Share
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
stevenckheng
noob company slowly moving a way from pharmaceutical
2023-09-06 20:25